Mercia Asset Management

Mercia Asset Management is a specialist asset manager based in the United Kingdom, focused on equity and debt investments to support the growth aspirations of regional businesses. The firm manages multiple funds, including venture capital funds dedicated to early-stage technology companies, particularly in the West Midlands. Mercia aims to provide a complete capital solution by investing across various asset classes, including venture and private equity. It emphasizes backing companies with strong growth potential and proprietary technology. The firm offers initial investments typically ranging from £50,000 to £250,000, with the capacity for follow-on investments up to £1 million per company. Mercia Asset Management also allows private investors to participate in high-growth technology companies through its Growth EIS Fund, benefiting from tax reliefs. Established in 1982, Mercia has established a reputation as a proactive partner for business owners, shareholders, and fund investors, aspiring to deliver superior returns.

Paul Arthur

Investment Director

Natalia Blagburn

Portfolio Director, NEVF and EIS

Chris Borrett

Investment Director

Ed Bradburn

Deputy Fund Principal

Ishaan Chilkoti

Partner

Andy Clough

Investment Manager

Brian Davidson

Operating Partner

Julian Dennard

Fund Principal, EIS / MEIF

Maurice Disasi

Investment Manager

Clive Downward

Investment Director

Martin Glanfield

CFO

Andy Green

Investment Director

Henry Hamilton

Investment Manager

Andy Heaton

Investment Manager

Stephen Johnson

Investment Director

Rafael Joseph

Investment Manager

Srikar Karri

Investment Manager

Warwick Ley

Investor and Operational Partner

Robin Lincoln

Operating Partner

Hugo Lough

Investment Director

Chris McCourt

Investment Director

Matthew Mead

Venture Partner

Kiran Mehta

Investment Manager

Jonny Nixon

Investment Director

Jan Oosthuizen

Investment Manager

Nigel Owens

Portfolio Director, VCT Funds

Mark Payton

CEO

Chris Pestell

Investment Director

Rebecca Pickering

Investment Manager

Mike Rogers

Investment Director

Peter Rooney

Investment Manager

Brijesh Roy

Investment Manager

William Schaffer

Investment Director

Peter Sorsby

Deputy Fund Principal - NPIF Debt

Paul Taberner

Managing Director, Mercia Debt Funds

Andy Tyas

Investment Manager

Angela Warner

Managing Director, Mercia Investments

Jason Warren

Partner, VCT Funds

Adam Watts

Investment Manager

Gary Whitaker

Investment Manager

Ian Wilson

Fund Principal

Stephen Windsor

Deputy Fund Principal

David Wright

Investment Manager

Past deals in Birmingham

AdaptTech

Venture Round in 2022
AdaptTech is a biomedical company based in Birmingham, United Kingdom, established in 2015. The company specializes in developing smart and wearable technologies aimed at enhancing the quality of life for individuals with physical limitations. Its flagship product, the INSIGHT Scanner, rapidly creates a three-dimensional model of prosthetic sockets in under 90 seconds. Complementing this, the INSIGHT Wearable device collects real-time biometric data from the user's stump, while the INSIGHT App provides convenient access to the gathered results. AdaptTech also offers an analysis pressure measurement system and a standalone digitizer specifically designed for prosthetic sockets, allowing clinicians to improve fitting and monitoring methods for lower limb prosthetics. Through these innovations, AdaptTech strives to support better outcomes for people experiencing lower-limb loss.

Kaido

Seed Round in 2022
Kaido will be stunning in its simplicity. Accessible via an easy to use app, it will use the very latest smart technology to serve up content endorsed by a global team of experts from the fields of sport, nutrition, education and psychology.

OneUp Sales

Seed Round in 2021
OneUp Sales is a sales management & motivation platform built for inside sales teams. The platform makes use of sales activity data from any source to drive gamified competitions, real-time TV leaderboards, and streamlined reporting for managers.

AdaptTech

Venture Round in 2021
AdaptTech is a biomedical company based in Birmingham, United Kingdom, established in 2015. The company specializes in developing smart and wearable technologies aimed at enhancing the quality of life for individuals with physical limitations. Its flagship product, the INSIGHT Scanner, rapidly creates a three-dimensional model of prosthetic sockets in under 90 seconds. Complementing this, the INSIGHT Wearable device collects real-time biometric data from the user's stump, while the INSIGHT App provides convenient access to the gathered results. AdaptTech also offers an analysis pressure measurement system and a standalone digitizer specifically designed for prosthetic sockets, allowing clinicians to improve fitting and monitoring methods for lower limb prosthetics. Through these innovations, AdaptTech strives to support better outcomes for people experiencing lower-limb loss.

Eyoto

Venture Round in 2021
Eyoto Group Limited specializes in designing and manufacturing innovative tools and software solutions for optical laboratories and retailers. The company offers a multifunction lens analyzer known as eMap, which enables dual lens power mapping and surface inspection. Additionally, Eyoto develops eBox, a mobile optometry solution that enhances the retail practice experience through a cloud-connected platform. This platform integrates portable hardware with artificial intelligence-driven software systems and extensive data analytics. Founded in 2013 and based in Birmingham, United Kingdom, Eyoto aims to transform eye care delivery globally by providing tele-optometry technology that offers an evidence-based dispensing experience, increased portability, and improved accuracy at a lower cost. The company was previously known as Aston EyeTech Ltd before rebranding in April 2019.

Irresistible Materials

Angel Round in 2018
Irresistible Materials Ltd, a materials technology company, develops and commercializes fullerene based photo-resist technology. It offers fullerene materials and processes for application in lithography, including EUV resists, spin-on-carbon, and e-beam resists. The company was incorporated in 2009 and is based in Swansea, United Kingdom.

Aston EyeTech Ltd

Series A in 2017
Aston EyeTech is a tech startup developing a range of proprietary hardware and software products for ocular care. It is revolutionizing the Ocular care ecosystem through increased portability, improved accuracy, and lower costs. The company is a spinout from Aston University’s School of Optometry. Aston EyeTech was founded in 2014 and is based in Birmingham, England.

Health Centrified

Seed Round in 2017
Health Centrified, a Birmingham, UK-based developer of a communication platform which offers secure digital access to healthcare services.The company intends to use the funds to support the development, evaluation and commercialisation of its software platform.

OneUp Sales

Seed Round in 2017
OneUp Sales is a sales management & motivation platform built for inside sales teams. The platform makes use of sales activity data from any source to drive gamified competitions, real-time TV leaderboards, and streamlined reporting for managers.

Kaido

Seed Round in 2016
Kaido will be stunning in its simplicity. Accessible via an easy to use app, it will use the very latest smart technology to serve up content endorsed by a global team of experts from the fields of sport, nutrition, education and psychology.

AdaptTech

Seed Round in 2016
AdaptTech is a biomedical company based in Birmingham, United Kingdom, established in 2015. The company specializes in developing smart and wearable technologies aimed at enhancing the quality of life for individuals with physical limitations. Its flagship product, the INSIGHT Scanner, rapidly creates a three-dimensional model of prosthetic sockets in under 90 seconds. Complementing this, the INSIGHT Wearable device collects real-time biometric data from the user's stump, while the INSIGHT App provides convenient access to the gathered results. AdaptTech also offers an analysis pressure measurement system and a standalone digitizer specifically designed for prosthetic sockets, allowing clinicians to improve fitting and monitoring methods for lower limb prosthetics. Through these innovations, AdaptTech strives to support better outcomes for people experiencing lower-limb loss.

Aston EyeTech Ltd

Seed Round in 2014
Aston EyeTech is a tech startup developing a range of proprietary hardware and software products for ocular care. It is revolutionizing the Ocular care ecosystem through increased portability, improved accuracy, and lower costs. The company is a spinout from Aston University’s School of Optometry. Aston EyeTech was founded in 2014 and is based in Birmingham, England.

Celentyx

Seed Round in 2007
Celentyx Ltd. is a pharmaceutical company based in Birmingham, United Kingdom, focused on developing treatments for diseases affecting the human immune system. The company offers an Immuno-Profiling platform that identifies therapeutic targets and facilitates the rapid analysis of drug actions on human immune cells. This platform is integral to their Novel Clinical Indication Profiling service, which is designed to reprofile existing drug candidates for immune-related diseases. Among its product offerings is CX1001, a therapy aimed at treating B-cell cancers. Additionally, Celentyx provides bespoke assay services in human immunology, covering areas such as immuno-oncology, autoimmunity, inflammation, fibrosis, and neuroinflammation. The company benefits from the expertise of its personnel and collaborations with notable research centers, allowing for advanced investigations into the human immune system in both health and disease. Celentyx Ltd. was incorporated in 2004.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.